NARA Discovery
Article Details
← Back to Search Results
Journal Article

Recommended Best Practices for Lyophilization Validation 2021 Part II: Process Qualification and Continued Process Verification

Feroz Jameel; Alina Alexeenko; Akhilesh Bhambhani; Gregory Sacha; Tong Zhu; Serguei Tchessalov; Puneet Sharma; Ehab Moussa; Lavanya Iyer; Sumit Luthra; Jayasree Srinivasan; Ted Tharp; Joseph Azzarella; Petr Kazarin; Mehfouz Jalal
AAPS PharmSciTech · Vol. 22, Issue 8 · 2021

Abstract

This work describes the lyophilization process validation and consists of two parts. Part one (Part I: Process Design and Modeling) focuses on the process design and is described in the previous paper, while the current paper is devoted to process qualification and continued process verification. The goal of the study is to show the cutting edge of lyophilization validation based on the integrated community-based opinion and the industrial perspective. This study presents best practices for batch size determination and includes the effect of batch size on drying time, process parameters selection strategies, and batch size overage to compensate for losses during production. It also includes sampling strategies to demonstrate batch uniformity as well as the use of statistical models to ensure adequate sampling. Based on the LyoHUB member organizations survey, the best practices in determining the number of PPQ runs are developed including the bracketing approach with minimum and maximum loads. Standard practice around CQA and CPP selection is outlined and shows the advantages of using control charts and run charts for process trending and quality control. The case studies demonstrating the validation strategy for monoclonal antibody and the impact of the loading process on the lyophilization cycle and product quality as well as the special case of lyophilization for dual-chamber cartridge system are chosen to illustrate the process validation. The standard practices in the validation of the lyophilization process, special lyophilization processes, and their impact on the validation strategy are discussed. Graphical Abstract

Bibliographic Information

JournalAAPS PharmSciTech
PublisherSpringer
Publication Date2021-11-01
Publication Year2021
Volume22
Issue8
Document TypeJournal Article
eISSN1530-9932
DOI10.1208/s12249-021-02107-6

Access Information

NARA Access Coverage2000-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12249
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.